220 related articles for article (PubMed ID: 28521461)
1. KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.
Hao YX; Li YM; Ye M; Guo YY; Li QW; Peng XM; Wang Q; Zhang SF; Zhao HX; Zhang H; Li GH; Zhu JH; Xiao WH
Oncol Lett; 2017 May; 13(5):3608-3616. PubMed ID: 28521461
[TBL] [Abstract][Full Text] [Related]
2. Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer.
Yokota T; Shibata N; Ura T; Takahari D; Shitara K; Muro K; Yatabe Y
Transl Res; 2010 Aug; 156(2):98-105. PubMed ID: 20627194
[TBL] [Abstract][Full Text] [Related]
3. Concomitant RAS and BRAF mutation in colorectal cancer - A report of 7 cases.
Ates O; Yalcin S
Indian J Cancer; 2019; 56(2):176-179. PubMed ID: 31062740
[TBL] [Abstract][Full Text] [Related]
4. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
Gao J; Sun ZW; Li YY; Shen L
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
[TBL] [Abstract][Full Text] [Related]
5. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
6. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.
Lee J; Lee I; Han B; Park JO; Jang J; Park C; Kang WK
J Natl Cancer Inst; 2011 Apr; 103(8):674-88. PubMed ID: 21398618
[TBL] [Abstract][Full Text] [Related]
7. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
8. [Molecular biological diagnostics of KRAS and BRAF mutations in patients with colorectal cancer - laboratory experience].
Robešová B; Bajerová M; Vašíková A; Ostřížková L; Hausnerová J; Kyclová J; Pospíšilová S; Mayer J; Dvořáková D
Klin Onkol; 2013; 26(1):25-30. PubMed ID: 23528169
[TBL] [Abstract][Full Text] [Related]
9. [Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma].
Ling Y; Ying JM; Qiu T; Shan L; Guo L; Lü N
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):590-4. PubMed ID: 23157825
[TBL] [Abstract][Full Text] [Related]
10. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
[TBL] [Abstract][Full Text] [Related]
11. The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population.
Ozen F; Ozdemir S; Zemheri E; Hacimuto G; Silan F; Ozdemir O
Genet Test Mol Biomarkers; 2013 Feb; 17(2):135-9. PubMed ID: 23297805
[TBL] [Abstract][Full Text] [Related]
12. Positive Correlation Between Somatic Mutations in RAS Gene and Colorectal Cancer in Telangana Population: Hospital-Based Study in a Cosmopolitan City.
Goud KI; Matam K; Madasu AM; Ali Khan I
Appl Biochem Biotechnol; 2020 Feb; 190(2):703-711. PubMed ID: 31475312
[TBL] [Abstract][Full Text] [Related]
13. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study.
Lee JH; Ahn J; Park WS; Choe EK; Kim E; Shin R; Heo SC; Jung S; Kim K; Chai YJ; Chae H
J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30658510
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
16. Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.
Pu X; Pan Z; Huang Y; Tian Y; Guo H; Wu L; He X; Chen X; Zhang S; Lin T
Oncol Lett; 2013 Jan; 5(1):249-254. PubMed ID: 23255930
[TBL] [Abstract][Full Text] [Related]
17. [Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma].
Zhang K; Xu J; Yan L; Liu X; Xu F; Liu Y
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):254-7. PubMed ID: 25975908
[TBL] [Abstract][Full Text] [Related]
18. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer.
Phua LC; Ng HW; Yeo AH; Chen E; Lo MS; Cheah PY; Chan EC; Koh PK; Ho HK
Oncol Lett; 2015 Oct; 10(4):2519-2526. PubMed ID: 26622882
[TBL] [Abstract][Full Text] [Related]
20. Correlation between clinicopathological features and
Zhu X; Meng X; Xiang W; Dai W; Bai Q; Sheng W; Lu Y; Qi P; Wu L; Cai G; Zhou X
Int J Clin Exp Pathol; 2018; 11(5):2839-2845. PubMed ID: 31938404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
